RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PHASE IIB TRIAL OF KETOROLAC MOUTH RINSE EVALUATING THE EFFECT OF CYCLOOXYGENASE INHIBITION ON OROPHARYNGEAL LEUKOPLAKIA: COLLABORATIVE STUDY OF THE NCI, NIDCD AND THE NIDCR: